Randomised, double-blind, placebo-controlled trial of faecal microbiota transplantation in patients with decompensated cirrhosis: the Livergut protocol
Abstract Introduction Cirrhosis represents the final stage of most chronic liver diseases and remains a major global cause of morbidity and mortality. Alterations in the gut microbiome correlate with disease severity and complications such as hepatic encephalopathy (HE) and acute-on-chronic liver failure (ACLF). Prelim...